Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image
Genomic and Precision Medicine: Oncology, Third Edition

Endometrial cancer

Publication ,  Chapter
Spinosa, D; Montes de Oca, MK; Watson, CH; Berchuck, A; Previs, RA
January 1, 2022

The prior dichotomous classification of endometrial cancer into high and low risk subtypes based primarily on histology has been shown to be inadequate in predicting outcome and treatment response. More nuanced molecular categorization of these cancers provides improved targeted therapeutic options and a better understanding of the different disease processes.

Duke Scholars

DOI

ISBN

9780128006535

Publication Date

January 1, 2022

Start / End Page

191 / 203
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Spinosa, D., Montes de Oca, M. K., Watson, C. H., Berchuck, A., & Previs, R. A. (2022). Endometrial cancer. In Genomic and Precision Medicine: Oncology, Third Edition (pp. 191–203). https://doi.org/10.1016/B978-0-12-800684-9.00014-9
Spinosa, D., M. K. Montes de Oca, C. H. Watson, A. Berchuck, and R. A. Previs. “Endometrial cancer.” In Genomic and Precision Medicine: Oncology, Third Edition, 191–203, 2022. https://doi.org/10.1016/B978-0-12-800684-9.00014-9.
Spinosa D, Montes de Oca MK, Watson CH, Berchuck A, Previs RA. Endometrial cancer. In: Genomic and Precision Medicine: Oncology, Third Edition. 2022. p. 191–203.
Spinosa, D., et al. “Endometrial cancer.” Genomic and Precision Medicine: Oncology, Third Edition, 2022, pp. 191–203. Scopus, doi:10.1016/B978-0-12-800684-9.00014-9.
Spinosa D, Montes de Oca MK, Watson CH, Berchuck A, Previs RA. Endometrial cancer. Genomic and Precision Medicine: Oncology, Third Edition. 2022. p. 191–203.
Journal cover image

DOI

ISBN

9780128006535

Publication Date

January 1, 2022

Start / End Page

191 / 203